跳至主要内容
临床试验/DRKS00024066
DRKS00024066尚未招募3 期

Glucocorticoid enhancement of food exposure therapy in Binge Eating Disorder - GEAR

niversitätsmedizin Göttingen0 个研究点目标入组 50 人开始时间: 2022年2月3日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 40 Years(—)
性别
All

入选标准

  • 1.18 - 40 years of age
  • 2.Patients must meet DSM-5 (APA, 2013) criteria of BED
  • 3.Willingness and ability to give written informed consent
  • 4.Female subjects of childbearing potential must agree to use acceptable method(s) of contraception for the full study duration.

排除标准

  • 1.systemic (i.v. or oral) glucocorticoid treatment within the last 3 months
  • 2.current diagnosis of a psychotic, bipolar, or substance use disorder
  • 3.severe somatic illness (e.g. cancer, cardiovascular disease)
  • 4.current use of psychotropic medication (at baseline)
  • 5.current or planned psychotherapy (during the period of the study)
  • 6.Simultaneous participation in another interventional trial
  • 7.Pregnant or breastfeeding females

研究者

发起方
niversitätsmedizin Göttingen

相似试验